Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
346
NCT01593254
Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib
Phase: Phase 2
Role: Collaborator
Start: Sep 12, 2012
Completion: Apr 12, 2022
NCT01850004
Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response
Start: Jan 22, 2014
Completion: Oct 8, 2021